Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Satellos Bioscience Inc T.MSCL

Alternate Symbol(s):  MSCLF

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this... see more

Bullboard (TSX:MSCL)

View:
Post by whytestockson Dec 17, 2024 5:45pm

Satellos Announces Pricing of US$40M Overnight Marketed Publ

BREAKING NEWS: $MSCLF Satellos Announces Pricing of US$40M Overnight Marketed Public OfferingBASE SHELF PROSPECTUS IS ACCESSIBLE, AND PROSPECTUS SUPPLEMENT WILL BE ACCESSIBLE WITHIN TWO BUSINESS DAYS ...more  
Post by Ike101on Dec 16, 2024 8:50pm

More Diltuion?

News today of public offering!
Post by Larder111on Dec 11, 2024 10:33am

Wow up up and away!!

Are we going to hit 1.50 today .this is crazy..
Post by whytestockson Nov 13, 2024 10:00pm

Satellos Reports Q3 2024 Financial Results and Provides Clin

Breaking News: $MSCLF Satellos Reports Q3 2024 Financial Results and Provides Clinical Update- Completed enrollment for SAT-3247 in Duchenne muscular dystrophy (DMD) in the first three (of five ...more  
Comment by BaddPitton Nov 05, 2024 10:19am

RE:RE:Webinar Recap: $MSCL CEO Frank Gleeson and CFO Liz Williams

Rug pull on horizon. Up on no volume. Bad look.
Comment by G1945Von Nov 04, 2024 7:53am

RE:Webinar Recap: $MSCL CEO Frank Gleeson and CFO Liz Williams

Satellos to Participate in November 2024 Investor Conferences
Post by bmreedon Sep 28, 2024 8:04pm

Webinar $MSCL CEO Frank Gleeson Oct 3 @ 1PM ET / 10AM PT

Live Webinar - Satellos Bioscience (MSCL) CEO Frank Gleeson and CFO Elizabeth Williams Thursday, October 3rd at 1PM ET / 10AM PT Q&A with Radius Research  Register Here - https ...more  
Post by G1945Von Jul 11, 2024 10:26am

Filing to Commence a Phase 1 Clinical Trial

Satellos Announces Submission of Regulatory Filing to Commence a Phase 1 Clinical Trial with SAT-3247  
Post by G1945Von Jul 02, 2024 7:59am

Preliminary Data Muscle Repair

Satellos Presents Preliminary Data Showing Muscle Repair and Regeneration from SAT-3247 Treatment in Canine Model of Duchenne Muscular Dystrophy ("DMD") G1945V
Post by bmreedon May 21, 2024 11:51am

Webinar $MSCL CEO Frank Gleeson May 23 @ 2PM ET / 11AM PT

Live Webinar - Satellos Bioscience Inc. (MSCL) w/ CEO Frank Gleeson Thursday, May 23rd at 2PM ET / 11AM PT Q&A with Radius Research  Register Here - https://us02web.zoom.us/webinar ...more  
Post by Drambueyon Apr 24, 2024 3:10pm

Post deleted SNOWFLAKES MANAGEMENT

So you deleted my post did it hit too close to home SNOWFLAKE MANAGEMENT?  Let me get this straight you roll back the stock 20 to one collect $1.4 million in salaries and the stock is trading at  ...more  
Comment by G1945Von Apr 24, 2024 7:13am

RE:You want to do what, AGAIN?

"you want to pass a resolution to roll this back again" Where is this coming from? G1945V
Post by beenthereon Mar 12, 2024 4:51pm

Sure Glad The Boys Moved To The TSX

Hate to think where we would be without that move!